Loading clinical trials...
Loading clinical trials...
Fetal Programming of Inflammatory Responses and Body Fat by Maternal Obesity: Role of DHA in the Modulation of Epigenetic Markers of Obesity and Metabolic Disease.
Conditions
Interventions
DHA
Locations
1
Chile
Red Salud UC Christus Hospital
Santiago, Santiago Metropolitan, Chile
Start Date
June 9, 2016
Primary Completion Date
March 30, 2020
Completion Date
June 1, 2020
Last Updated
June 24, 2020
NCT01143454
NCT07472881
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
Pontificia Universidad Catolica de Chile
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions